References
Adak, A., & Khan, M.R. (2019). An insight into gut microbiota and its functionalities. Cellular & Molecular Life Sciences, 76(3), 473-493. https://doi.org/10.1007/s00018-018-2943-4
PMid:30317530
Ahmed, M.M., Chowdhury, A., Malaker, R., Hossain, M.N., Fakruddin, M., & Noor, R. (2013). Bacteriocin Profiling of Probiotic Lactobacillus spp. Isolated from Yoghurt. International Journal of Pharmaceutical Chemistry, 3(3), 50-6.
Andrade, J.C., Almeida, D., Domingos, M., Seabra, C.L., Machado, D., Freitas, A.C., & Gomes, A.M. (2020). Commensal Obligate Anaerobic Bacteria and Health: Production, Storage, and Delivery Strategies. Frontiers in Bioengineering and Biotechnology, 8, 550.
https://doi.org/10.3389/fbioe.2020.00550
PMid:32582673 PMCid:PMC7291883
Anvar, A. A., & Nowruzi, B. (2021). Bioactive Properties of Spirulina: A Review. Microbial Bioactives, 4(1), 134-142. https://doi.org/10.25163/microbbioacts.412117B0719110521
Bilen, M., Dufour, J.C., Lagier, J.C., Cadoret, F., Daoud, Z., Dubourg, G., & Raoult, D. (2018). The contribution of culturomics to the repertoire of isolated human bacterial and archaeal species. Microbiome, 6, 94. https://doi.org/10.1186/s40168-018-0485-5
PMid:29793532 PMCid:PMC5966928
Bottacini, F., van Sinderen, D., & Ventura, M. (2017). Omics of bifidobacteria: research and insights into their health promoting activities. Biochemistry Journal, 474, 4137e52.
https://doi.org/10.1042/BCJ20160756
PMid:29212851
Brodmann, T., Endo, A., Gueimonde, M., Vinderola, G., Kneifel, W., De Vos, W.M., Salminen, S. & Gómez-Gallego, C. (2017). Safety of Novel Microbes for Human Consumption: Practical Examples of Assessment in the European Union. Frontiers in Microbiology, 8, 1725.
https://doi.org/10.3389/fmicb.2017.01725
PMid:28955311 PMCid:PMC5601064
Breton, J., Galmiche, M., & Dechelotte, P. (2022). Dysbiotic Gut Bacteria in Obesity: An Overview of the Metabolic Mechanisms and Therapeutic Perspectives of Next-Generation Probiotics. Microorganisms, 10(2), 452.
https://doi.org/10.3390/microorganisms10020452
PMid:35208906 PMCid:PMC8877435
Bron, P.A., Kleerebezem, M., Brummer, R.-J., Cani. P.D., Mercenier, A., MacDonald, T.T., Garcia-Rodenas, C.L., & Wells, J.M. (2017). Can probiotics modulate human disease by impacting intestinal barrier function? British Journal of Nutrition, 117(1), 93-107.
https://doi.org/10.1017/S0007114516004037
PMid:28102115 PMCid:PMC5297585
Bunesova, V., Lacroix, C. & Schwab, C. (2018). Mucin Cross-Feeding of Infant Bifidobacteria and Eubacterium hallii. Microbial Ecology, 75, 228-238.
https://doi.org/10.1007/s00248-017-1037-4
PMid:28721502
Byndloss, M.X., Olsan, E.E., Rivera- Chavez, F., Tiffany, C.R., Cevallos, S.A., Lokken, K.L.,………., Baumler, A.J. (2017). Microbiota activated PPARgamma signaling inhibits dysbiotic Enterobacteriaceae expansion. Science, 357, 570e5.
https://doi.org/10.1126/science.aam9949
PMid:28798125 PMCid:PMC5642957
Cani, P.D., & de Vos, W.M. (2017). Next-generation beneficial microbes: the case of Akkermansia muciniphila. Frontiers in Microbiology, 8, 1765.
https://doi.org/10.3389/fmicb.2017.01765
PMid:29018410 PMCid:PMC5614963
Carlsson, A.H., Yakymenko, O., Olivier, I., Håkansson, F., Postma, E., Keita, Å.V., & Söderholm, J.D. (2013). Faecalibacterium prausnitzii supernatant improves intestinal barrier function in mice DSS colitis. Scandinavian Journal of Gastroenterology, 48, 1136-1144.
https://doi.org/10.3109/00365521.2013.828773
PMid:23971882
Cassir, N., Benamar, S., & La Scola, B. (2016). Clostridium butyricum: from beneficial to a new emerging pathogen. Clinical Microbiology and Infection, 22, 37-45.
https://doi.org/10.1016/j.cmi.2015.10.014
PMid:26493849
Chang, C.-J., Lin, C.-S., Lu, C.-C., Martel, J., Ko, Y.-F., Ojcius, D.M.,…….., Lai, H.-C. (2015). Ganoderma lucidum reduces obesity in mice by modulating the composition of the gut microbiota. Nature Communications, 6, 7489.
https://doi.org/10.1038/ncomms8489
PMid:26102296 PMCid:PMC4557287
Chang, C.J., Lin, T.L., Tsai, Y.L.,….., Lai, H.-C. (2019). Next generation probiotics in disease amelioration. Journal of Food & Drug Analysis, 27(3), 615-22.
https://doi.org/10.1016/j.jfda.2018.12.011
PMid:31324278
Chaput, N., Lepage, P., Coutzac, C.,……., Carbonnel, F. (2017). Baseline gut microbiota predicts clinical response and colitis in metastatic melanoma patients treated with ipilimumab. Annals of Oncology, 28, 1368e79.
https://doi.org/10.1093/annonc/mdx363.021
https://doi.org/10.1093/annonc/mdx108
PMid:28368458
Chen, D., Jin, D., Huang, S., Wu, J., Xu, M., Liu, T., Dong, W., Liu, X., Wang, S., Zhong, W., Liu, Y., Jiang, R., Piao, M., Wang, B., & Cao, H. (2020). Clostridium butyricum, a butyrate-producing probiotic, inhibits intestinal tumor development through modulating Wnt signaling and gut microbiota. Cancer Letters, 469, 456-467.
https://doi.org/10.1016/j.canlet.2019.11.019
PMid:31734354
Chowdhury, A., Hossain, M.N., Mostazir, N.J., Fakruddin, M., Billah, M.M., & Ahmed, M.M. (2012). Screening of Lactobacillus spp. From buffalo yoghurt for probiotic and antibacterial activity. Journal of Bacteriology and Parasitology, 3, 156.
https://doi.org/10.4172/2155-9597.1000156
Clarke, G., Stilling, R.M., Kennedy, P.J., Stanton, C., Cryan, J.F., & Dinan, T.G. (2014). Minireview: gut microbiota: the neglected endocrine organ. Molecular Endocrinology, 28, 1221e38.
https://doi.org/10.1210/me.2014-1108
PMid:24892638 PMCid:PMC5414803
Collado, M. C., Derrien, M., Isolauri, E., De Vos, W. M., & Salminen, S. (2007). Intestinal Integrity and Akkermansia muciniphila, a Mucin-Degrading Member of the Intestinal Microbiota Present in Infants, Adults, and the Elderly. Applied and Environmental Microbiology, 73, 7767.
https://doi.org/10.1128/AEM.01477-07
PMid:17933936 PMCid:PMC2168041
Cunningham, M., Azcarate-Peril, M.A., Barnard, A., …….. , Gibson, G.R. (2021). Shaping the future of probiotics and prebiotics. Trends in Microbiology, 29(8), 667-685.
https://doi.org/10.1016/j.tim.2021.01.003
PMid:33551269
De Vadder, F., Kovatcheva-Datchary, P., Zitoun, C., Duchampt, A., Backhed, F., & Mithieux, G. (2016). Microbiota- produced succinate improves glucose homeostasis via intestinal gluconeogenesis. Cell Metabolism, 24, 151e7.
https://doi.org/10.1016/j.cmet.2016.06.013
PMid:27411015
Derrien, M., Belzer, C., & De Vos, W. M. (2017). Akkermansia muciniphila and its role in regulating host functions. Microbial Pathogenesis, 106, 171-181.
https://doi.org/10.1016/j.micpath.2016.02.005
PMid:26875998
Derrien, M., Vaughan, E.E., Plugge, C.M., & De Vos, W.M. (2004). Akkermansia muciniphila gen. nov., sp. nov., a human intestinal mucin-degrading bacterium. International Journal of Systematic & Evolutionary Microbiology, 54, 1469-1476. https://doi.org/10.1099/ijs.0.02873-0
PMid:15388697
Douillard, F.P., & de Vos, W.M. (2019). Biotechnology of health-promoting bacteria. Biotechnology Advances, 37(6), 107369. https://doi.org/10.1016/j.biotechadv.2019.03.008
PMid:30876799
Duncan, S.H., Louis, P., & Flint, H.J. (2004). Lactate-Utilizing Bacteria, Isolated from Human Feces, That Produce Butyrate as a Major Fermentation Product. Applied and Environmental Microbiology, 70, 5810. https://doi.org/10.1128/AEM.70.10.5810-5817.2004
PMid:15466518 PMCid:PMC522113
Engels, C., Ruscheweyh, H.-J., Beerenwinkel, N., Lacroix, C., & Schwab, C. (2016). The Common Gut Microbe Eubacterium hallii also Contributes to Intestinal Propionate Formation. Frontiers in Microbiology, 7, 713-713. https://doi.org/10.3389/fmicb.2016.00713
PMid:27242734 PMCid:PMC4871866
Everard, A., Belzer, C., Geurts, L.,………, Cani, P.D. (2013). Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proceedings of the National Academy of Sciences, 110, 9066e71. https://doi.org/10.1073/pnas.1219451110
PMid:23671105 PMCid:PMC3670398
Everard, A., Belzer, C., Geurts, L., Ouwerkerk, J. P., Druart, C., Bindels, L. B., Guiot, Y., Derrien, M., Muccioli, G. G., Delzenne, N. M., De Vos, W. M., & Cani, P. D. (2013). Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proceedings of the National Academy of Sciences, 110(22), 9066. https://doi.org/10.1073/pnas.1219451110
PMid:23671105 PMCid:PMC3670398
Fakruddin, M., Hossain, M.N., & Ahmed M.M. (2017). Antimicrobial and antioxidant activities of Saccharomyces cerevisiae IFST062013, a potential probiotic. BMC Complementary & Alternative Medicine, 17, 64. https://doi.org/10.1186/s12906-017-1591-9
PMid:28109187 PMCid:PMC5251302
Ferdous, U. T., Shishir, M. A., Khan, S. N., & Hoq, M. M. (2018). Bacillus spp.: Attractive Sources of Anti-cancer and Anti-proliferative Biomolecules. Microbial Bioactives, 1(1), E033-E045.
https://doi.org/10.25163/microbbioacts.11005B0408130818
Fernández-Murga, M.L., & Sanz, Y. (2016). Safety Assessment of Bacteroides uniformis CECT 7771 Isolated from Stools of Healthy Breast-Fed Infants. PLOS ONE, 11, e0145503.
https://doi.org/10.1371/journal.pone.0145503
PMid:26784747 PMCid:PMC4718450
Ferreira-Halder, C.V., Faria, A.V.d.S., & Andrade, S.S. (2017). Action and function of Faecalibacterium prausnitzii in health and disease. Best Practice & Research Clinical Gastroenterology, 31, 643-648. https://doi.org/10.1016/j.bpg.2017.09.011
PMid:29566907
Goloshchapov, O.V., Bakin, E.A., Kucher, M.A.,……., Chukhlovin, A.B. (2020). Bacteroides fragilis is a potential marker of effective microbiota transplantation in acute graft-versus-host disease treatment. Cellular Therapy and Transplantation, 9(2), 47-59.
https://doi.org/10.18620/ctt-1866-8836-2020-9-2-47-59
Goodrich, J.K., Davenport, E.R., Beaumont, M.,……, Ley, R.E. (2016) Genetic determinants of the gut microbiome in UK twins. Cell Host & Microbe, 19, 731e43.
https://doi.org/10.1016/j.chom.2016.04.017
PMid:27173935 PMCid:PMC4915943
Goodrich, J.K., Waters, J.L., Poole, A.C.,…….., Ley, R.E. (2014). Human genetics shape the gut microbiome. Cell, 159, 789e99. https://doi.org/10.1016/j.cell.2014.09.053
PMid:25417156 PMCid:PMC4255478
Gopalakrishnan, V., Spencer, C.N., Nezi, L.,…….., Wargo, J.A. (2018). Gut microbiome modulates response to anti- PD-1 immunotherapy in melanoma patients. Science, 359, 97e103.
https://doi.org/10.1126/science.aan4236
PMid:29097493 PMCid:PMC5827966
Hamer, H.M., Jonkers, D., Venema, K., Vanhoutvin, S., Troost, F.J., & Brummer, R.J. (2008). Review article: the role of butyrate on colonic function. Alimentary Pharmacology & Therapeutics, 27, 104-119. https://doi.org/10.1111/j.1365-2036.2007.03562.x
PMid:17973645
Han, W., & Zhuang, X. (2021). Research progress on the next generation probiotic Akkermansia muciniphila in the intestine. Food Frontiers, 2, 443-448. https://doi.org/10.1002/fft2.87
He, X., Zhao, S., & Li, Y. (2021). Faecalibacterium prausnitzii: A next-generation probiotic in gut disease improvement. Canadian Journal of Infectious Diseases and Medical microbiology, id: 6666114. https://doi.org/10.1155/2021/6666114
https://doi.org/10.1155/2021/6666114
Heinken, A., Khan, M.T., Paglia, G., Rodionov, D.A., Harmsen, H.J.M., & Thiele, I. (2014). Functional Metabolic Map of a Beneficial Human Gut Microbe. Journal of Bacteriology, 196, 3289.
https://doi.org/10.1128/JB.01780-14
PMid:25002542 PMCid:PMC4135701
Heintz-Buschart, A., Pandey, U., Wicke, T.,…….., Wilmes, P. (2018). The nasal and gut microbiome in Parkinson's disease and idiopathic rapid eye movement sleep behaviour disorder. Movement Disorders, 33, 88e98. https://doi.org/10.1002/mds.27105
PMid:28843021 PMCid:PMC5811909
Hill, C., Guarner, F., Reid, G., Gibson, G.R., Merenstein, D.J., Pot, B., Morelli, L., Canani, R.B., Flint, H.J., Salminen, S., Calder, P.C., & Sanders, M.E. (2014). The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nature Reviews Gastroenterology & Hepatology, 11, 506-514.
https://doi.org/10.1038/nrgastro.2014.66
PMid:24912386
Husted, A.S., Trauelsen, M., Rudenko, O., Hjorth, S., & Schwartz, T.W. (2017). GPCR-mediated signaling of metabolites. Cell Metabolism, 25, 777e96.
https://doi.org/10.1016/j.cmet.2017.03.008
PMid:28380372
Kazmierczak-Siedlecka, K., Skonieczna-Zydecka, K., Hupp, T., Duchnowska, R., Marek-Trzonkowska, N., & Polom, K. (2022). Next generation probiotics- do they open new therapeutic strategies for cancer patients? Gut Microbes, 14(1), e2035659. https://doi.org/10.1080/19490976.2022.2035659
PMid:35167406 PMCid:PMC8855854
Kimura, I., Inoue, D., Hirano, K., & Tsujimoto, G. (2014). The SCFA receptor GPR43 and energy metabolism. Frontiers in Endocrinology, 5, 85. https://doi.org/10.3389/fendo.2014.00085
PMid:24926285 PMCid:PMC4046487
Levy, M., Kolodziejczyk, A.A., Christoph, A.T., & Elinav, E. (2017). Dysbiosis and the immune system. Nature Reviews Immunology, 17, 219-232. https://doi.org/10.1038/nri.2017.7
PMid:28260787
Li, C., Chen, X., Kou, L.,……, Xu, G.-X. (2010). Selenium-Bifidobacterium longum as a delivery system of endostatin for inhibition of pathogenic bacteria and selective regression of solid tumor. Experimental and Therapeutic Medicine, 1, 129e35. https://doi.org/10.3892/etm_00000022
PMid:23136605 PMCid:PMC3490391
Lin, T-L., Shu, C-C., Lai, W-F., Tzeng, C-M., Lai, H-C., & Lu, C-C. (2019). Investiture of next generation probiotics on amelioration of diseases- Strains do matter. Medicine in Microecology, 1-2, 100002. https://doi.org/10.1016/j.medmic.2019.100002
Lopez-Moreno, A., Acuna, I., Torres-Sanchez, A., …….. , Aguilera, M. (2021). Next generation probiotics for neutralizing obesogenic effects: Taxa culturing searching strategies. Nutrients, 13, 1617. https://doi.org/10.3390/nu13051617
https://doi.org/10.3390/nu13051617
PMid:34065873 PMCid:PMC8151043
Louis, P., Young, P., Holtrop, G., & Flint, H. (2009). Diversity of human colonic butyrate-producing bacteria revealed by analysis of the butyryl-CoA: acetate CoA-transferase gene. Environmental Microbiology, 12, 304-314.
https://doi.org/10.1111/j.1462-2920.2009.02066.x
PMid:19807780
Lukiw, W.J. (2016). Bacteroides fragilis lipopolysaccharide and inflammatory signaling in alzheimer's disease. Frontiers in Microbiology, 7, 1544.
https://doi.org/10.3389/fmicb.2016.01544
PMid:27725817 PMCid:PMC5035737
Miquel, S., Martin, R., Rossi, O.,……, Lengella, P. (2013). Faecalibacterium prausnitzii and human intestinal health. Current Opinion in Microbiology, 16, 255e61.
https://doi.org/10.1016/j.mib.2013.06.003
PMid:23831042
Miyaoka, T.M., Kanayama, M.M.W., Rei M.D., Hashioka, S.M.,……..., Horiguchi, J. (2018). Clostridium butyricum MIYAIRI 588 as Adjunctive Therapy for Treatment-Resistant Major Depressive Disorder: A Prospective Open-Label Trial. Clinical Neuropharmacology, 41, 151-155.
https://doi.org/10.1097/WNF.0000000000000299
PMid:30234616
Nowruzi, B., Shishir, M. A., Porzani, S. J., & Ferdous, U. T. (2022). Exploring the Interactions between Algae and Bacteria. Mini Reviews in Medicinal Chemistry.
https://doi.org/10.2174/1389557522666220504141047
O'toole, P., Marchesi, J., & Hill, C. (2017). Next-generation probiotics: The spectrum from probiotics to live biotherapeutics. Nature Microbiology, 2, 17057.
https://doi.org/10.1038/nmicrobiol.2017.57
PMid:28440276
Olveira, G., & Gonzalez-Molero, I. (2016). An update on probiotics, prebiotics and symbiotics in clinical nutrition. Endocrinologia y Nutricion, 63, 482e94.
https://doi.org/10.1016/j.endoen.2016.10.011
Pesce, M., Seguella, L., Del Re, A.,……, Esposito, G. (2022). Next-generation probiotics for inflammatory bowel disease. International Journal of Molecular Sciences, 22, 5466.
https://doi.org/10.3390/ijms23105466
PMid:35628274 PMCid:PMC9141965
Pitt, J.M., Vetizou, M., Boneca I.G., Lepage, P., Chamaillard, M., & Zitvogel, L. (2017). Enhancing the clinical coverage and anticancer efficacy of immune checkpoint blockade through manipulation of the gut microbiota. Oncoimmunology, 6, e1132137.
https://doi.org/10.1080/2162402X.2015.1132137
PMid:28197360 PMCid:PMC5283646
Reunanen, J., Kainulainen, V., Huuskonen, L., Ottman, N., Belzer, C., Huhtinen, H., De Vos, W. M., & Satokari, R. (2015). Akkermansia muciniphila Adheres to Enterocytes and Strengthens the Integrity of the Epithelial Cell Layer. Applied and Environmental Microbiology, 81, 3655.
https://doi.org/10.1128/AEM.04050-14
PMid:25795669 PMCid:PMC4421065
Rong, Y., Dong, Z., Hong, Z.,……, Lu, Y. (2017). Reactivity toward Bifidobacterium longum and Enterococcus hirae demonstrate robust CD8+ T cell response and better prognosis in HBV-related hepatocellular carcinoma. Experimental Cellular Research, 358, 352e9.
https://doi.org/10.1016/j.yexcr.2017.07.009
PMid:28694023
Round, J.L., & Mazmanian, S.K. (2010). Inducible Foxp3. Regulatory T-cell development by a commensal bacterium of the intestinal microbiota. Proceedings of the National Academy of Sciences, 107, 12204e9. https://doi.org/10.1073/pnas.0909122107
PMid:20566854 PMCid:PMC2901479
Routy, B., Le Chatelier, E., Derosa, L,……., Zitvogel, L. (2018). Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors. Science, 359, 91e7.
https://doi.org/10.1126/science.aan3706
PMid:29097494
Saarela, M.H. (2019). Safety aspects of next generation probiotics. Current Opinion in Food Science, 30, 8-13. https://doi.org/10.1016/j.cofs.2018.09.001
Schneeberger, M., Everard, A., Gomez-Valades, A.G.,….., Cani, P.D. (2015). Akkermansia muciniphila inversely correlates with the onset of inflammation, altered adipose tissue metabolism and metabolic disorders during obesity in mice. Scientific Reports, 5, 16643.
https://doi.org/10.1038/srep16643
PMid:26563823 PMCid:PMC4643218
Shyam, K.U., Krishnan, R., Jeena, K., Vijaysunderdeva, G., & Prasad, K.P. (2021). Next-generation probiotics- Future therapeutics for sustainable aquaculture. Aquaculture, 25(4), 23-26.
Sivan, A., Corrales, L., Hubert, N.,……, Gajewski, T. (2015). Commensal Bifidobacterium promotes antitumor immunity and facilitates anti- PD-L1 efficacy. Science, 350, 1084e9.
https://doi.org/10.1126/science.aac4255
PMid:26541606 PMCid:PMC4873287
Sun, F., Zhang, Q., Zhao, J., Zhang, H., Zhai, Q., & Chen, W. (2019). A potential species of next-generation probiotics? The dark and light sides of Bacteroides fragilis in health. Food Research International, 126, 108590. https://doi.org/10.1016/j.foodres.2019.108590
PMid:31732047
Sun, J., Wang, F., Ling, Z., Yu, X., Chen, W., Li, H., Jin, J., Pang, M., Zhang, H., Yu, J., & Liu, J. (2016). Clostridium butyricum attenuates cerebral ischemia/reperfusion injury in diabetic mice via modulation of gut microbiota. Brain Research, 1642, 180-188.
https://doi.org/10.1016/j.brainres.2016.03.042
PMid:27037183
Syakila, R.N., Lim, S.M., Agatonovic-Kustrin, S., Lim, F.T., & Ramasamy, K. (2019). In vitro assessment of pediococci- and lactobacilli-induced cholesterol-lowering effect using digitally enhanced high-performance thin-layer chromatography and confocal microscopy. Analytical and Bioanalytical Chemistry, 411, 1181-1192.
https://doi.org/10.1007/s00216-018-1544-2
PMid:30680424
Tan, H., Wang, C., Zhang, Q., Tang, X., Zhao, J., Zhang, H., Zhai, Q., & Chen, W. (2020). Preliminary safety assessment of a new Bacteroides fragilis isolate. Food and Chemical Toxicology, 135, 110934.
https://doi.org/10.1016/j.fct.2019.110934
PMid:31682931
Tan, H., Zhai, Q., & Chen, W. (2019). Investigations of Bacteroides spp. towards next-generation probiotics. Food Research International, 116, 637-644.
https://doi.org/10.1016/j.foodres.2018.08.088
PMid:30716990
Torp, A.M., Bahl, M.I., Boisen, A., & Licht, T.R. (2022). Optimizing oral delivery of next generation probiotics. Trends in Food Science & Technology, 119, 101-109. https://doi.org/10.1016/j.tifs.2021.11.034
Udayappan, S., Manneras-Holm, L., Chaplin-Scott, A., Belzer, C., Herrema, H., Dallinga-Thie, G.M., Duncan, S.H., Stroes, E.S.G., Groen, A.K., Flint, H.J., Backhed, F., De Vos, W.M., & Nieuwdorp, M. (2016). Oral treatment with Eubacterium hallii improves insulin sensitivity in db/db mice. NPJ Biofilms and Microbiomes, 2, 16009. https://doi.org/10.1038/npjbiofilms.2016.9
PMid:28721246 PMCid:PMC5515273
Wu, T.R., Lin, C.S., Chang, C.J.,……, Lai, H.-C. (2019). Gut commensal Parabacteroides goldsteinii plays a predominant role in the anti-obesity effects of polysaccharides isolated from Hirsutella sinensis. Gut, 68(2), 248e62. https://doi.org/10.1136/gutjnl-2017-315458
PMid:30007918
Yang, J., Li, Y., Wen, Z., Liu, W., Meng, L., & Huang, H. (2021). Oscilliporia- a candidate for the next generation probiotics. Gut Microbes, 13(1), e1987783. https://doi.org/10.1080/19490976.2021.1987783
PMid:34693878 PMCid:PMC8547878
Zhang, M., Qiu, X., Zhang, H., Yang, X., Hong, N., Yang, Y., Chen, H., & Yu, C. (2014). Faecalibacterium prausnitzii inhibits interleukin-17 to ameliorate colorectal colitis in rats. PloS One, 9, e109146-e109146. https://doi.org/10.1371/journal.pone.0109146
PMid:25275569 PMCid:PMC4183556
Zhang, W., Zhu, B., Xu, J., Liu, Y., Qiu, E., Li, Z., Li, Z., He, Y., Zhou, H., Bai, Y., & Zhi, F. (2018). Bacteroides fragilis Protects Against Antibiotic-Associated Diarrhea in Rats by Modulating Intestinal Defenses. Frontiers in Immunology, 9, 1040. https://doi.org/10.3389/fimmu.2018.01040
PMid:29868005 PMCid: PMC5954023